VRTX earnings: next report 2026-08-03, real EPS beat/miss history, analyst consensus Buy, P/E 27.78. Updated 2026-07-23.
Vertex Pharmaceuticals (VRTX) Research Hub
Vertex Pharmaceuticals (VRTX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 515.44 USD (-1.09%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 27.78, market cap 119.73B. This hub links to the full technical, earnings and options research available for VRTX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 515.44 USD (-1.09%) |
| 52-week range | 439.5 USD – 560.25 USD |
| Trend regime | Range |
| 14-day RSI | 55.9 (Bullish) |
| Trailing P/E | 27.78 |
| Market cap | 119.73B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-03 |
Available research for VRTX
Covered Call on VRTX: how it works, illustrative setup around the real 515.44 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on VRTX: how it works, illustrative setup around the real 515.44 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on VRTX: how it works, illustrative setup around the real 515.44 USD price, max profit/loss, breakeven and when to use it. Educational.
VRTX technical analysis: range, last 515.44 USD, RSI 55.9, 52w range 439.5 USD–560.25 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is VRTX in?
Vertex Pharmaceuticals (VRTX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is VRTX in an uptrend or downtrend?
As of 2026-09-11, VRTX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is VRTX's trailing P/E ratio?
VRTX's trailing P/E is 27.78, with a market cap of 119.73B. See the earnings research page for full valuation detail.
When does VRTX next report earnings?
VRTX is next scheduled to report earnings on 2026-08-03, with a consensus EPS estimate of 4.74 USD.